2The Expert Committee of the Diagnosis and Classification of Diabetes Mellitus. Report of the EXPERT Committee on the Diagnosis and Classificataion of Diabetes Mellitus [J]. Diabetes Care,1997, 20: 1183-97.
3Tuomi T, Groop LC, Zimmet PZ, et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes in adults with a non-insulin-dependent onset of disease[J]. Diabetes, 1993,42: 359-362.
4Torn C, Landin-Olsson M, Lernmark A, et al. Prognostic factors for the course of 3 cell function in autoimmune diabetes [J]. J Clin Endocrinol Metab, 2000, 85: 4619-4623.
5Turner R, Stratton I, Horton V, et al. UKPDS25 autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes [J]. Lancet,1997, 350: 1288-1293.
6Kobayashi T, Nakanishi K, Murase T, et al. Small doses of subcutaeous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM[J]. Diabetes, 1996, 45: 622-626.
